University Hospital Muenster - Developmental Therapeutics Review - Q4 2010

Global Markets Direct, December 2010, Pages: 43

University Hospital Muenster – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “University Hospital Muenster – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by University Hospital Muenster.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of University Hospital Muenster with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of University Hospital Muenster’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Identify new drug targets and therapeutic classes in University Hospital Muenster’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate University Hospital Muenster’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of University Hospital Muenster in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with University Hospital Muenster.
- Avoid Intellectual Property Rights related issues.

List of Tables
List of Figures
University Hospital Muenster Snapshot
University Hospital Muenster Overview
Key Information
Key Facts
University Hospital Muenster – Research and Development Overview
Key Therapeutic Areas
University Hospital Muenster – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
University Hospital Muenster – Pipeline Products Glance
University Hospital Muenster – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
University Hospital Muenster Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
University Hospital Muenster – Drug Profiles
Anthracyclines + liposomal daunorubicin + 2-CDA + AI
Product Description
Mechanism of Action
R&D Progress
Busulfan
Product Description
Mechanism of Action
R&D Progress
Cladribine
Product Description
Mechanism of Action
R&D Progress
Cytarabine + Thioguanine + Daunorubicin + Cyclophosphamide + G-CSF
Product Description
Mechanism of Action
R&D Progress
Cytarabine + Thioguanine + Daunorubicin + Cyclophosphamide + G-CSF + stem cell transplantation
Product Description
Mechanism of Action
R&D Progress
Daunoxome
Product Description
Mechanism of Action
R&D Progress
lidocaine
Product Description
Mechanism of Action
R&D Progress
Liposomal Daunorubicin
Product Description
Mechanism of Action
R&D Progress
Testosterone Gel
Product Description
Mechanism of Action
R&D Progress
Treosulfan
Product Description
Mechanism of Action
R&D Progress
Zoledronic acid
Product Description
Mechanism of Action
R&D Progress
Azacitidine + Daunorubicin + Cytarabine
Product Description
Mechanism of Action
R&D Progress
granulocyte - colony stimulating factor (G-CSF) + erythropoetin (EPO)
Product Description
Mechanism of Action
R&D Progress
injection of hormonal male contraceptive
Product Description
Mechanism of Action
R&D Progress
University Hospital Muenster – Pipeline Analysis
University Hospital Muenster – Pipeline Products by Therapeutic Class
University Hospital Muenster Pipeline Products By Target
University Hospital Muenster – Pipeline Products by Route of Administration
University Hospital Muenster – Pipeline Products by Molecule Type
University Hospital Muenster - Dormant Projects
University Hospital Muenster – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Charter Schools - Global Outlook
• Education Services - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• International Military and Government Helicopter Survey
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Generic Defense Strategies: Lifecycle Management Strategies to Maximize Revenue in the Face of Growing Generic Competition